Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant.
Abstract
cells could lead to durable anti-HIV-1 activity. Nullbasic, as a gene therapy candidate, could be a part of a functional-cure strategy to suppress HIV-1 transcription and replication.
| Authors | Jin, Hongping; Sun, Yifan; Li, Dongsheng; Lin, Min-Hsuan; Lor, Mary; Rustanti, Lina; Harrich, David |
|---|---|
| Journal | MBIO |
| Pages | |
| Volume | 10 |
| Date | 1/08/2019 |
| Grant ID | 1104034 |
| Funding Body | Australian Research Council |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1128/mBio.01769-19 |